AdvisorShares Pure US Cannabis ETF

The Department of Health and Human Services (HHS) suggested the DEA reclassify cannabis as a Schedule III controlled substance under federal law. Assistant Secretary for Health Rachel Levine's letter triggered a much-needed rally in cannabis stocks. In a recent analyst note, a...

In the ever-evolving world of investment, cannabis exchange-traded funds (ETFs) have found themselves in a precarious position in 2023. Amid a backdrop of struggling cannabis stocks and changing market dynamics, industry experts are raising concerns about the efficacy of certain cannabis-focused...